"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

Summary

The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD.

Timeline

Start

2024-12-17

Primary completion

2026-08

Completion

2026-09

Drugs

Indications